Literature DB >> 128409

Effect of levamisole (NSC-177023) on DNA synthesis by lymphocytes from immunosuppressed C57BL mice.

W A Woods, M J Filegelman, M A Chirigos.   

Abstract

The effect of in vivo treatment of C57BL mice with BCNU and/or levamisole on the in vitro DNA synthetic capacity of their spleen cells was studied as a measure of cell-mediated immune function. BCNU treatment was suppressive to spleen cell DNA synthesis; conversely, treatment with levamisole was stimulatory. Levamisole treatment 5-8 days after BCNU treatment resulted in significant recovery of DNA synthetic capacity. Multiple doses of levamisole were not more effective than single doses. Allogeneic stimulation of BCNU-suppressed lymphocytes was not consistently increased by levamisole treatment.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 128409

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


  5 in total

1.  The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.

Authors:  J Drews
Journal:  Infection       Date:  1985       Impact factor: 3.553

2.  Levamisole as an immunotherapeutic agent in the treatment of cancer.

Authors:  W K Amery
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

3.  Immunostimulation. Clinical and experimental perspectives.

Authors:  J Drews
Journal:  Klin Wochenschr       Date:  1984-03-15

4.  The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.

Authors:  J Drews
Journal:  Infection       Date:  1984 Mar-Apr       Impact factor: 3.553

5.  Restoration by levamisole of immune responses suppressed in tumor-bearing mice.

Authors:  M Shiraishi; K Himeno; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.